Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

Erectile dysfunction (ED) is a common condition affecting millions of men worldwide. While traditional treatments, such as medications and surgical methods, offer temporary relief, new advancements in ...

Add Yahoo as a preferred source to see more of our stories on Google. Erectile dysfunction can cause a “self-perpetuating cycle of anxiety and performance pressure,” says one expert. (Photo ...

New ED Formulation Puts Focus on Men's Sexual Health as Part of Overall Wellness TAMPA, Fla., Jan. 28, 2026 /PRNewswire/ -- BoomRx, the fastest-growing national pharmaceutical technology platform that ...

Kranus Health GmbH has raised $6.5 million in series A funding to ramp commercialization of its digital therapy for treating erectile dysfunction (ED). Eleven European investors participated in this ...

No need to be in your flop era. Between 30 million and 50 million men in the US have erectile dysfunction (ED) — defined as difficulty getting and keeping an erection — including a staggering 70% of ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) failed to improve erectile dysfunction (ED) versus a sham procedure in men who had undergone radical prostatectomy, a small randomized trial ...